Cullen Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,690
| Closed | -$1.4M | – | 212 |
|
|
2023
Q2 | $1.4M | Sell |
2,690
-126
| -4% | -$68K | 0.01% | 189 |
|
|
2023
Q1 | $1.62M | Buy |
2,816
+640
| +29% | +$361K | 0.01% | 175 |
|
|
2022
Q4 | $1.2M | Sell |
2,176
-621
| -22% | -$329K | 0.02% | 139 |
|
|
2022
Q3 | $1.42M | Buy |
2,797
+39
| +1% | +$21.8K | 0.02% | 177 |
|
|
2022
Q2 | $1.5M | Buy |
2,758
+38
| +1% | +$20.9K | 0.02% | 177 |
|
|
2022
Q1 | $1.61M | Sell |
2,720
-4,195
| -61% | -$2.41M | 0.01% | 172 |
|
|
2021
Q4 | $4.61M | Sell |
6,915
-155
| -2% | -$96.8K | 0.04% | 142 |
|
|
2021
Q3 | $4.04M | Sell |
7,070
-334
| -5% | -$183K | 0.04% | 136 |
|
|
2021
Q2 | $3.73M | Sell |
7,404
-187
| -2% | -$88.2K | 0.04% | 136 |
|
|
2021
Q1 | $3.46M | Buy |
7,591
+5,696
| +301% | +$2.72M | 0.04% | 137 |
|
|
2020
Q4 | $883K | Hold |
1,895
| – | – | 0.05% | 99 |
|
|
2020
Q3 | $837K | Hold |
1,895
| – | – | 0.05% | 98 |
|
|
2020
Q2 | $687K | Sell |
1,895
-710
| -27% | -$238K | 0.04% | 104 |
|
|
2020
Q1 | $739K | Hold |
2,605
| – | – | 0.04% | 99 |
|
|
2019
Q4 | $846K | Sell |
2,605
-600
| -19% | -$182K | 0.03% | 95 |
|
|
2019
Q3 | $934K | Sell |
3,205
-1,295
| -29% | -$371K | 0.04% | 98 |
|
|
2019
Q2 | $1.32M | Hold |
4,500
| – | – | 0.05% | 99 |
|
|
2019
Q1 | $1.23M | Hold |
4,500
| – | – | 0.05% | 90 |
|
|
2018
Q4 | $1.01M | Hold |
4,500
| – | – | 0.04% | 95 |
|
|
2018
Q3 | $1.1M | Hold |
4,500
| – | – | 0.04% | 99 |
|
|
2018
Q2 | $932K | Hold |
4,500
| – | – | 0.04% | 107 |
|
|
2018
Q1 | $929K | Hold |
4,500
| – | – | 0.03% | 111 |
|
|
2017
Q4 | $854K | Hold |
4,500
| – | – | 0.03% | 116 |
|
|
2017
Q3 | $851K | Hold |
4,500
| – | – | 0.03% | 113 |
|
|
2017
Q2 | $785K | Hold |
4,500
| – | – | 0.03% | 114 |
|
|
2017
Q1 | $691K | Hold |
4,500
| – | – | 0.02% | 124 |
|
|
2016
Q4 | $635K | Sell |
4,500
-3,250
| -42% | -$479K | 0.02% | 135 |
|
|
2016
Q3 | $1.23M | Hold |
7,750
| – | – | 0.04% | 116 |
|
|
2016
Q2 | $1.15M | Hold |
7,750
| – | – | 0.04% | 110 |
|
|
2016
Q1 | $1.1M | Hold |
7,750
| – | – | 0.04% | 114 |
|
|
2015
Q4 | $1.1M | Hold |
7,750
| – | – | 0.04% | 114 |
|
|
2015
Q3 | $948K | Hold |
7,750
| – | – | 0.03% | 118 |
|
|
2015
Q2 | $1.01M | Hold |
7,750
| – | – | 0.03% | 126 |
|
|
2015
Q1 | $1.04M | Hold |
7,750
| – | – | 0.03% | 125 |
|
|
2014
Q4 | $971K | Hold |
7,750
| – | – | 0.03% | 124 |
|
|
2014
Q3 | $943K | Hold |
7,750
| – | – | 0.03% | 125 |
|
|
2014
Q2 | $914K | Hold |
7,750
| – | – | 0.02% | 139 |
|
|
2014
Q1 | $932K | Hold |
7,750
| – | – | 0.03% | 128 |
|
|
2013
Q4 | $863K | Hold |
7,750
| – | – | 0.02% | 117 |
|
|
2013
Q3 | $714K | Hold |
7,750
| – | – | 0.02% | 121 |
|
|
2013
Q2 | $656K | Buy |
+7,750
| New | +$645K | 0.02% | 103 |
|
Other funds holding TMO
Cullen Capital Management's TMO Position: Q3 2023 in Review
Cullen Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 2,690 shares — an estimated $1.4M sold.
Cullen Capital Management first reported a position in TMO in Q2 2013 and held it in 41 quarters. The position peaked at $4.61M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Cullen Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
- Cullen Capital Management sold 2,690 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.4M.
- Cullen Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 41 quarters.
- Cullen Capital Management's Thermo Fisher Scientific position peaked at $4.61M in Q4 2021.
- 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Cullen Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.